Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

4 terminated/withdrawn out of 28 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

43%

12 trials in Phase 3/4

Results Transparency

35%

7 of 20 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

Phase 3

10(47.6%)

N/A

4(19.0%)

Phase 2

3(14.3%)

Phase 4

2(9.5%)

Phase 1

2(9.5%)

21Total

Phase 3(10)

N/A(4)

Phase 2(3)

Phase 4(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials

NCT02972281Not ApplicableCompleted

Systematic Search for Primary Immunodeficiency in Adults With Infections

Role: collaborator

NCT06257407Recruiting

Perioperative Hemostasis Management in Liver Transplantation

Role: collaborator

NCT02352181Not ApplicableCompleted

Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.

Role: collaborator

NCT05695391Phase 3Terminated

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM

Role: lead

NCT05904210Completed

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Role: lead

NCT01676688Completed

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Role: lead

NCT05664035Not Yet Recruiting

SPAD in Adult Patients

Role: collaborator

NCT02448680Phase 3Completed

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa